Generic Afinitor (Everolimus)

Same Active Ingredient, 87% Less Cost

FDA-approved mTOR inhibitor for kidney, breast cancer, and neuroendocrine tumors

Brand vs. Generic Comparison

Factor Afinitor (Brand) Generic Everolimus
Active Ingredient Everolimus 5mg, 10mg Everolimus 5mg, 10mg
Manufacturer Novartis Natco / Cipla / Sun Pharma
Monthly Cost ~$11,000 ~$1,430
Savings 87%
FDA Approval ✓ Yes ✓ Yes
WHO-GMP Certified ✓ Yes ✓ Yes

What is Generic Everolimus?

Everolimus is an FDA-approved mammalian target of rapamycin (mTOR) inhibitor used to treat advanced renal cell carcinoma, HR-positive HER2-negative breast cancer, and neuroendocrine tumors. Generic Everolimus contains the identical active ingredient as brand-name Afinitor but at a fraction of the cost.

Indications (Uses)

  • Advanced Renal Cell Carcinoma — Kidney cancer treatment
  • HR-Positive HER2-Negative Breast Cancer — Advanced metastatic breast cancer
  • Neuroendocrine Tumors (NET) — Including pancreatic and gastrointestinal NETs

Strengths Available

5mg and 10mg tablets — Standard dosing: typically 10mg once daily; may be adjusted based on individual tolerance

Why Choose Generic Everolimus?

  • 87% Cost Savings — ~$1,430/month vs. ~$11,000 for brand Afinitor
  • Same Active Ingredient — Identical therapeutic action as Afinitor
  • FDA-Approved — Meets rigorous US pharmaceutical standards
  • WHO-GMP Certified — Manufactured under strict international quality guidelines
  • Global Supply — Reliable sourcing from trusted generic manufacturers (Natco, Cipla, Sun Pharma)

Browse Our Everolimus Products

Find generic Everolimus for kidney cancer, breast cancer, and neuroendocrine tumor treatment:

Kidney Cancer

Generic Everolimus for advanced renal cell carcinoma

View Products

Why Trust Our Generic Everolimus?

FDA Approval

Generic Everolimus is FDA-approved for renal cell carcinoma, breast cancer, and neuroendocrine tumors. It meets the same rigorous standards as brand Afinitor.

WHO-GMP Certified

All our manufacturers comply with WHO Good Manufacturing Practice standards, ensuring quality and safety.

Bioequivalent to Afinitor

Generic Everolimus has demonstrated bioequivalence to brand Afinitor in clinical studies, ensuring identical mTOR inhibition and therapeutic action.

Trusted Manufacturers

We source from Natco, Cipla, and Sun Pharma—globally recognized generic pharmaceutical manufacturers with extensive oncology expertise.

Frequently Asked Questions

Is generic Everolimus as effective as Afinitor?

Yes. Generic Everolimus contains the identical active ingredient (Everolimus) and has been proven bioequivalent to brand Afinitor. Both deliver the same mTOR inhibition and therapeutic effect.

Why is generic Everolimus so much cheaper?

Generic manufacturers don’t incur the same research, development, and marketing costs as the original developer (Novartis). Once patent protection expires, generics can be manufactured more cost-effectively, resulting in 87% savings for patients.

What is the standard dosage?

The standard dose is 10mg once daily. However, dosing may be adjusted based on body weight, liver function, and tolerance. Always follow your physician’s specific dosage instructions.

Can Everolimus be taken with food?

Everolimus should be taken consistently, either with or without food, at the same time each day. However, taking it with food may reduce nausea. Consult your physician for specific guidance.

What are common side effects?

Common side effects include stomatitis (mouth sores), diarrhea, fatigue, and rash. Most are manageable with medical supervision and supportive care. Your oncologist can recommend strategies to minimize side effects.

Is a prescription required?

Yes. Everolimus is a prescription-only medication and must be prescribed by a licensed medical professional (oncologist or physician). We accept valid prescriptions during checkout.

Medical Disclaimer

This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with a licensed physician or oncologist before starting, changing, or stopping any medication, including generic Everolimus. The information provided here does not constitute medical advice and should not be used for self-diagnosis.

Generic Everolimus is used as prescribed by a licensed medical professional. Individual results may vary. OnlineMeds.org is not responsible for any adverse effects or outcomes resulting from the use of this medication. Always follow your physician’s dosage and usage instructions.

]]>